Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,628Revenue $M173Net Margin (%)59.6Z-Score29.2
Enterprise Value $M1,439EPS $3.3Operating Margin %68.1F-Score6
P/E(ttm))25.5Cash Flow Per Share $-0.9Pre-tax Margin (%)68.2Higher ROA y-yY
Price/Book7.810-y EBITDA Growth Rate %0Quick Ratio9.2Cash flow > EarningsY
Price/Sales10.35-y EBITDA Growth Rate %0Current Ratio9.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)90.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)106Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M28.5ROI % (ttm)-59.8Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NLNKJean-Marie Eveillard 2014-03-31 Add0.02%$21.38 - $50.4
($33.68)
$ 57.1741%Add 28.35%1,161,805
NLNKJean-Marie Eveillard 2013-09-30 Add0.01%$15.78 - $20.08
($17.83)
$ 57.1769%Add 21.32%778,354
NLNKJean-Marie Eveillard 2013-06-30 Add0.02%$11.27 - $22.56
($15.73)
$ 57.1772%Add 95.04%641,554
NLNKJean-Marie Eveillard 2013-03-31 Buy 0.01%$11.4 - $12.7
($12.08)
$ 57.1779%New holding328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wiley BrianVP of Business Development 2015-02-17Sell10,000$40.0730.42view
Ramsey William J.Quality Assurance Officer 2015-02-17Sell2,500$4030.65view
Link Charles J. Jr.Chairman of the Board and CEO 2015-02-05Sell20,000$32.4161.25view
Ramsey William J.Quality Assurance Officer 2015-01-23Sell2,500$4030.65view
Link Charles J. Jr.Chairman of the Board and CEO 2015-01-07Sell20,000$37.9937.56view
Wiley BrianVP of Business Development 2015-01-02Sell20,000$40.3329.58view
Link Charles J. Jr.Chairman of the Board and CEO 2014-12-04Sell20,000$37.8438.11view
HENNEMAN JOHN B IIIEVP, CFO 2014-11-25Buy5,000$34.3552.14view
Link Charles J. Jr.Chairman of the Board and CEO 2014-11-10Sell20,000$32.9458.65view
LINK GORDON H JRCFO 2014-10-24Sell2,500$40.3929.39view

Press Releases about NLNK :

    Quarterly/Annual Reports about NLNK:

    News about NLNK:

    Articles On GuruFocus.com
    NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
    Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 


    More From Other Websites
    The Zacks Analyst Blog Highlights: Horizon Pharma, NewLink Genetic and llumina - Press Releases Mar 27 2015
    Two experimental Ebola vaccines pass safety test in African trial Mar 26 2015
    Two experimental Ebola vaccines pass safety test in African trial Mar 26 2015
    3 Excellent Biotech Stocks to Buy on the Dip - Stocks in the News Mar 25 2015
    NEWLINK GENETICS CORP Financials Mar 21 2015
    NEWLINK GENETICS CORP Files SEC form 10-K, Annual Report Mar 16 2015
    NEWLINK GENETICS CORP Files SEC form 8-K/A, Entry into a Material Definitive Agreement Mar 13 2015
    Can the Rally in NewLink Genetics (NLNK) Shares Continue? - Tale of the Tape Mar 10 2015
    Biotech Stock Mailbag: Next Biotech Takeout Targets, NewLink Genetics Mar 06 2015
    Analysts' Actions: Crane, Lumber Liquidators, NewLink Genetics, Tutor Perini and More Mar 02 2015
    Decision on Ebola mass vaccination in August at earliest - WHO Feb 27 2015
    Decision on Ebola mass vaccination in August at earliest - WHO Feb 27 2015
    Decision on widespread Ebola vaccination in August at earliest - WHO Feb 27 2015
    Decision on widespread Ebola vaccination in August at earliest - WHO Feb 27 2015
    NewLink beats 4Q profit forecasts Feb 26 2015
    NewLink beats 4Q profit forecasts Feb 26 2015
    NewLink Genetics Corporation Provides Operational Update and Reports Fourth Quarter and Year End... Feb 26 2015
    NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition Feb 26 2015
    NewLink Genetics Corporation Provides Operational Update and Reports Fourth Quarter and Year End... Feb 26 2015
    Medicago wins contract to develop Ebola treatments Feb 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK